In certain types of cancer, a high level of TRIP12 mRNA is associated with a shorter disease-free survival (i.e., bladder urothelial carcinoma, pancreatic adenocarcinoma), which suggests that the TRIP12 mRNA level could be a useful prognostic marker. This evidence concerns the gene TRIP12 and bladder transitional cell carcinoma.